Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.

Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849 · see citing works

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922 · see citing works

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907 · see citing works

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688 · see citing works

SCANPY: large-scale single-cell gene expression data analysis

Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881 · see citing works

The Perseus computational platform for comprehensive analysis of (prote)omics data

Tyanova, S., Temu, T., Sinitcyn, P. G., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 7,977 · see citing works

Global quantification of mammalian gene expression control

Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · see citing works

Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage

Aran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984 · see citing works

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405 · see citing works

Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling

Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets

Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304 · cited 1× · see citing works

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · cited 1× · see citing works

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · see citing works

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543 · see citing works

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., & Hamon, C. (2003) · Analytical Chemistry · doi:10.1021/ac0262560 · Cited by 2,386 · see citing works

Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes

Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187 · see citing works

The Architecture of SARS-CoV-2 Transcriptome

Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · see citing works

Towards a systems understanding of MHC class I and MHC class II antigen presentation

Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044 · see citing works

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887 · see citing works

Recovering Gene Interactions from Single-Cell Data Using Data Diffusion

van Dijk, D., Sharma, R., Nainys, J., Yim, K., Kathail, P., Carr, A. J., Burdziak, C., Moon, K. R., Chaffer, C. L., Pattabiraman, D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.061 · Cited by 1,829 · see citing works

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · see citing works

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569 · see citing works

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 920 · see citing works

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907 · see citing works

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Chen, R. E., Zhang, X., Case, J. B., Winkler, E. S., Liu, Y., VanBlargan, L. A., Liu, J., Errico, J. M., Xie, X., Suryadevara, N., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01294-w · Cited by 881 · see citing works

Efficient integration of heterogeneous single-cell transcriptomes using Scanorama

Hie, B., Bryson, B. D., & Berger, B. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0113-3 · Cited by 853 · see citing works

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706 · see citing works

Negligible impact of SARS-CoV-2 variants on CD4 + and CD8 + T cell reactivity in COVID-19 exposed donors and vaccinees

(2021) · doi:10.1101/2021.02.27.433180 · Cited by 706 · see citing works

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Stukalov, A., Girault, V., Grass, V., Karayel, Ö., Bergant, V., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03493-4 · Cited by 656 · see citing works

Pervasive functional translation of noncanonical human open reading frames

Chen, J., Brunner, A., Cogan, J. Z., Nuñez, J. K., Fields, A. P., Adamson, B., Itzhak, D. N., Li, J. Y., Mann, M., Leonetti, M. D., et al. (2020) · Science · doi:10.1126/science.aay0262 · Cited by 654 · see citing works

Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes

Ingolia, N. T., Brar, G. A., Stern‐Ginossar, N., Harris, M. S., Talross, G. J. S., Jackson, S. E., Wills, M. R., & Weissman, J. S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.045 · Cited by 644 · see citing works

The coding capacity of SARS-CoV-2

Finkel, Y., Mizrahi, O., Nachshon, A., Weingarten-Gabbay, S., Morgenstern, D., Yahalom-Ronen, Y., Tamir, H., Achdout, H., Stein, D., Israeli, O., et al. (2021) · Nature · doi:10.1038/s41586-020-2739-1 · Cited by 644 · see citing works

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Schubert, K. N., Karousis, E. D., Jomaa, A., Scaiola, A., Echeverria, B., Gurzeler, L., Leibundgut, M., Thiel, V., Mühlemann, O., & Ban, N. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0511-8 · Cited by 605 · see citing works

Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction

Abelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J. D., Lane, W. J., Zhang, G., Eisenhaure, T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 593 · see citing works

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Su, Y., Chen, D., Yuan, D., Lausted, C. G., Choi, J., Dai, C. L., Voillet, V., Duvvuri, V. R. S. K., Scherler, K., Troisch, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.037 · Cited by 591 · see citing works

Decoding Human Cytomegalovirus

Stern-Ginossar, N., Weisburd, B., Michalski, A., Le, V. T. K., Hein, M. Y., Huang, S.-X., Ma, M., Shen, B., Qian, S.-B., Hengel, H., et al. (2012) · Science · doi:10.1126/science.1227919 · Cited by 589 · see citing works

Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2

Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020) · Journal of Virology · doi:10.1128/jvi.00510-20 · Cited by 562 · see citing works

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100204 · Cited by 540 · see citing works

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι

Zhang, Y., Chen, Y., Li, Y., Huang, F., Luo, B., Yuan, Y., Xia, B., Ma, X., Yang, T., Yu, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024202118 · Cited by 528 · see citing works

A large peptidome dataset improves HLA class I epitope prediction across most of the human population

Sarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 505 · see citing works

The race for coronavirus vaccines: a graphical guide

Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-01221-y · Cited by 492 · see citing works

MHC class I antigen presentation: learning from viral evasion strategies

Hansen, T. H., & Bouvier, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2575 · Cited by 427 · see citing works

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

Wu, K., Werner, A. P., Koch, M., Choi, A., Narayanan, E., Stewart-Jones, G. B. E., Colpitts, T., Bennett, H., Boyoglu-Barnum, S., Shi, W., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102179 · Cited by 409 · see citing works

The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development

Dutta, N. K., Mazumdar, K., & Gordy, J. T. (2020) · Journal of Virology · doi:10.1128/jvi.00647-20 · Cited by 407 · see citing works

Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studies

Solberg, O. D., Mack, S. J., Lancaster, A. K., Single, R. M., Tsai, Y., Sanchez‐Mazas, A., & Thomson, G. J. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.05.001 · Cited by 345 · see citing works

The SARS-CoV-2 RNA–protein interactome in infected human cells

Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 320 · see citing works

Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein

Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318 · see citing works

Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer

Ouspenskaia, T., Law, T. E., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01021-3 · Cited by 303 · see citing works

SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

Finkel, Y., Gluck, A., Nachshon, A., Winkler, R., Fisher, T., Rozman, B., Mizrahi, O., Lubelsky, Y., Zuckerman, B., Slobodin, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03610-3 · Cited by 260 · see citing works

Two complementary methods for predicting peptides binding major histocompatibility complex molecules

Gulukota, K., Sidney, J., Sette, A., & DeLisi, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0937 · Cited by 259 · see citing works

SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals

Kared, H., Redd, A. D., Bloch, E. M., Bonny, T. S., Sumatoh, H., Kairi, F., Carbajo, D., Abel, B., Newell, E. W., Bettinotti, M. P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145476 · Cited by 257 · see citing works

SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection

Altmann, D., & Boyton, R. (2020) · Science immunology · doi:10.1126/sciimmunol.abd6160 · Cited by 255 · see citing works

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D. O., Titov, A., Peshkova, I. O., Khmelevskaya, A. A., Dianov, D. V., Malasheva, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.004 · Cited by 222 · see citing works

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients

Saini, S. K., Hersby, D. S., Tamhane, T., Povlsen, H. R., Hernandez, S. P. A., Nielsen, M., Gang, A. O., & Hadrup, S. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7550 · Cited by 222 · see citing works

Improved Ribo-seq enables identification of cryptic translation events

Erhard, F., Halenius, A., Zimmermann, C., L’Hernault, A., Kowalewski, D. J., Weekes, M. P., Stevanović, S., Zimmer, R., & Dölken, L. (2018) · Nature Methods · doi:10.1038/nmeth.4631 · Cited by 208 · see citing works

Most non-canonical proteins uniquely populate the proteome or immunopeptidome

Cuevas, M. V. R., Hardy, M., Hollý, J., Bonneil, É., Durette, C., Courcelles, M., Lanoix, J., Côté, C., Staudt, L. M., Lemieux, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108815 · Cited by 204 · see citing works

High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome

Chong, C., Marino, F., Pak, H., Racle, J., Daniel, R. T., Müller, M., Gfeller, D., Coukos, G., & Bassani‐Sternberg, M. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir117.000383 · Cited by 197 · see citing works

The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-IPreprint

Zhang, Y., Zhang, J., Chen, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.24.111823 · Cited by 192 · see citing works

Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype

Habel, J. R., Nguyen, T. H. O., van de Sandt, C. E., Juno, J. A., Chaurasia, P., Wragg, K. M., Koutsakos, M., Hensen, L., Jia, X., Chua, B. Y. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015486117 · Cited by 182 · see citing works

Kinetics of Antigen Expression and Epitope Presentation during Virus Infection

Croft, N. P., Smith, S. A., Wong, Y. C., Tan, C. T., Dudek, N. L., Flesch, I. E. A., Lin, L. C. W., Tscharke, D. C., & Purcell, A. W. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003129 · Cited by 161 · see citing works

Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionPreprint

Dan, J., Mateus, J., Kato, Y., Hastie, K., Yu, E., Faliti, C. E., Grifoni, A., Ramirez, S., Haupt, S., Frazier, A., et al. (2020) · bioRxiv · doi:10.1101/2020.11.15.383323 · Cited by 147 · see citing works

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVPreprint

Stukalov, A., Girault, V., Grass, V., Karayel, O., Bergant, V., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.17.156455 · Cited by 144 · see citing works

Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide–HLA Interactions

Bassani‐Sternberg, M., & Gfeller, D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600808 · Cited by 134 · see citing works

Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture

Sidney, J., Southwood, S., Moore, C., Oseroff, C., Pinilla, C., Grey, H. M., & Sette, A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1803s100 · Cited by 133 · see citing works

Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.

Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2020) · eScholarship (California Digital Library) · Cited by 121 · see citing works

CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants

Redd, A. D., Nardin, A., Kared, H., Bloch, E. M., Pekosz, A. S., Laeyendecker, O. B., Abel, B., Fehlings, M., Quinn, T. C., & Tobian, A. A. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab143 · Cited by 105 · see citing works

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

Poran, A., Harjanto, D., Malloy, M., Arieta, C. M., Rothenberg, D. A., Lenkala, D., van Buuren, M. M., Addona, T. A., Rooney, M. S., Srinivasan, L., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00767-w · Cited by 102 · see citing works

MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells

Altman, J. D., & Davis, M. M. (2016) · Current Protocols in Immunology · doi:10.1002/cpim.14 · Cited by 99 · see citing works

Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine

Zhu, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.01.001 · Cited by 96 · see citing works

Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses

Wu, T., Guan, J. Z., Handel, A., Tscharke, D. C., Sidney, J., Sette, A., Wakim, L. M., Sng, X. Y. X., Thomas, P. G., Croft, N. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10661-8 · Cited by 96 · see citing works

Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposurePreprint

Francis, J. M., Leistritz-Edwards, D., Dunn, A., Tarr, C., Lehman, J. W., Dempsey, C., Hamel, A., Rayon-Estrada, V., Liu, G., Wang, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1126/sciimmunol.abk3070 · Cited by 90 · see citing works

On programmed ribosomal frameshifting: the alternative proteomes

Ketteler, R. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00242 · Cited by 80 · see citing works

Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance

Starck, S. R., & Shastri, N. (2016) · Immunological Reviews · doi:10.1111/imr.12434 · Cited by 76 · see citing works

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes

McMurtrey, C., Lelic, A., Piazza, P. A., Chakrabarti, A. K., Yablonsky, E. J., Wahl, A. R., Bardet, W., Eckerd, A., Cook, R. L., Hess, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711874105 · Cited by 67 · see citing works

CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variantsPreprint

Redd, A., Nardin, A., Kared, H., et al. (2021) · medRxiv · doi:10.1101/2021.02.11.21251585 · Cited by 65 · see citing works

SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in CellsPreprint

Andres, A. D., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B. P., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256776 · Cited by 63 · see citing works

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells

Ternette, N., Yang, H., Partridge, T., Llano, A., Cedeño, S., Fischer, R., Charles, P. D., Dudek, N. L., Mothe, B., Casal, M. C., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545890 · Cited by 58 · see citing works

Immune evasion via SARS-CoV-2 ORF8 protein?

Park, M. D. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0360-z · Cited by 58 · see citing works

Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture

Lunemann, S., Schöbel, A., Kah, J., Fittje, P., Hölzemer, A., Langeneckert, A. E., Hess, L. U., Poch, T., Martrus, G., García-Beltrán, W. F., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.019 · Cited by 51 · see citing works

Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution

Jungreis, I., Nelson, C. W., Ardern, Z., Finkel, Y., Krogan, N. J., Sato, K., Ziebuhr, J., Stern‐Ginossar, N., Pavesi, A., Firth, A. E., et al. (2021) · Virology · doi:10.1016/j.virol.2021.02.013 · Cited by 51 · see citing works

Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity

Keskin, D. B., Reinhold, B. B., Zhang, G., Ivanov, A. R., Karger, B. L., & Reinherz, E. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423482112 · Cited by 50 · see citing works

Prioritization of SARS-CoV-2 epitopes using a pan-HLA and global population inference approachPreprint

Campbell, K. M., Steiner, G., Wells, D. K., Ribas, A., & Kalbasi, A. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.30.016931 · Cited by 46 · see citing works

Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancerPreprint

Ouspenskaia, T., Law, T. E., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.12.945840 · Cited by 45 · see citing works

Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features

Finkel, Y., Schmiedel, D., Tai-Schmiedel, J., Nachshon, A., Winkler, R., Dobešová, M., Schwartz, M., Mandelboim, O., & Stern‐Ginossar, N. (2020) · eLife · doi:10.7554/elife.50960 · Cited by 38 · see citing works

How ‘killer’ T cells could boost COVID immunity in face of new variants

Ledford, H. K. (2021) · Nature · doi:10.1038/d41586-021-00367-7 · Cited by 38 · see citing works

SARS -CoV-2 T-cell immunity to variants of concern following vaccinationPreprint

Gallagher, K., Leick, M. B., Larson, R. C., Berger, T. R., Katsis, K., Yam, J. Y., Brini, G., Grauwet, K., MGH COVID-19 Collection & Processing Team, & Maus, M. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.03.442455 · Cited by 32 · see citing works

Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation

Schellens, I. M. M., Meiring, H. D., Hoof, I., Spijkers, S., Poelen, M. C. M., den Brink, J. A. M. V. G.-V., Costa, A. I., Vennema, H., Keşmir, C., van Baarle, D., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00546 · Cited by 29 · see citing works

Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs

Yang, N., Gibbs, J. S., Hickman, H. D., Reynoso, G. V., Ghosh, A. K., Bennink, J. R., & Yewdell, J. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502303 · Cited by 28 · see citing works

Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome

Demmers, L. C., Heck, A. J. R., & Wu, W. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00821 · Cited by 27 · see citing works

Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8 + T Cell Recognition In Vivo

Takagi, A., & Matsui, M. (2020) · Journal of Virology · doi:10.1128/jvi.01837-20 · Cited by 25 · see citing works

CD8 + T Cell Recognition of Cryptic Epitopes Is a Ubiquitous Feature of AIDS Virus Infection

Maness, N. J., Walsh, A. D., Piaskowski, S. M., Furlott, J. R., Kolar, H. L., Bean, A. T., Wilson, N. A., & Watkins, D. I. (2010) · Journal of Virology · doi:10.1128/jvi.01419-10 · Cited by 22 · see citing works

Influenza A Virus Negative Strand RNA Is Translated for CD8+ T Cell Immunosurveillance

Hickman, H. D., Mays, J. W., Gibbs, J. S., Košík, I., Magadán, J. G., Takeda, K., Das, S. R., Reynoso, G. V., Ngudiankama, B. F., Wei, J., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800586 · Cited by 20 · see citing works

SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathwayPreprint

Chen, D. W., Khan, N., Close, B. J., Goel, R. K., Blum, B. C., Tavares, A. H., Kenney, D., Conway, H. L., Ewoldt, J. K., Kapell, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.27.358259 · Cited by 20 · see citing works

Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses

Ručević, M., Kourjian, G., Boucau, J., Blatnik, R., García-Beltrán, W. F., Berberich, M. J., Walker, B. D., Riemer, A. B., & Gall, S. L. (2016) · Journal of Virology · doi:10.1128/jvi.00599-16 · Cited by 19 · see citing works

Untitled work

(2000) · doi:10.1002/1098-2272(200101)20:1

The T cell immune response against SARS-CoV-2

Moss, P. A. H. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,205 · see citing works

COVID-19 mRNA vaccines: Platforms and current developments

Szabó, G. T., Mahiny, A. J., & Vlatkovic, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.016 · Cited by 308 · see citing works

Advances and Utility of the Human Plasma Proteome

Deutsch, E. W., Omenn, G. S., Sun, Z., Maes, M., Pernemalm, M., Palaniappan, K. K., Letunica, N., Vandenbrouck, Y., Brun, V., Tao, S., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00657 · Cited by 238 · see citing works

T Cell Responses to SARS-CoV-2

Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 181 · see citing works

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity

Lim, J. M. E., Tan, A. T., Bert, N. L., Hang, S. K., Low, J. G. H., & Bertoletti, A. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220780 · Cited by 114 · see citing works

SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic

Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.008 · Cited by 115 · see citing works

SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression

Arshad, N., Laurent-Rolle, M., Ahmed, W. S., Hsu, J. C.-C., Mitchell, S. M., Pawlak, J., Sengupta, D., Biswas, K. H., & Cresswell, P. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208525120 · Cited by 119 · see citing works

A streamlined platform for analyzing tera-scale DDA and DIA mass spectrometry data enables highly sensitive immunopeptidomics

Xin, L., Qiao, R., Chen, X., Tran, N. H., Pan, S., Rabinoviz, S., Bian, H., He, X., Morse, B., Shan, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30867-7 · Cited by 101 · see citing works

Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposurePreprint

Francis, J. M., Leistritz-Edwards, D., Dunn, A., Tarr, C., Lehman, J. W., Dempsey, C., Hamel, A., Rayon-Estrada, V., Liu, G., Wang, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1126/sciimmunol.abk3070 · Cited by 90 · see citing works

The impact of immunopeptidomics: From basic research to clinical implementation

Shapiro, I. E., & Bassani‐Sternberg, M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101727 · Cited by 87 · see citing works

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection

Arieta, C. M., Xie, Y. J., Rothenberg, D., Diao, H., Harjanto, D., Meda, S., Marquart, K., Koenitzer, B., Sciuto, T. E., Lobo, A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.007 · Cited by 85 · see citing works

HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection

Augusto, D. G., & Hollenbach, J. A. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102178 · Cited by 73 · see citing works

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults

Kared, H., Wolf, A., Alirezaylavasani, A., Ravussin, A., Solum, G., Tran, T. T., Lund‐Johansen, F., Vaage, J. T., Nissen‐Meyer, L. S. H., Nygaard, U. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31888-y · Cited by 65 · see citing works

Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion

Mazzoni, A., Salvati, L., Maggi, L., Annunziato, F., & Cosmi, L. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101508 · Cited by 65 · see citing works

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues

Abelin, J. G., Bergstrom, E. J., Rivera, K. D., Taylor, H. B., Klaeger, S., Xu, C., Verzani, E. K., White, C. J., Woldemichael, H. B., Virshup, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37547-0 · Cited by 61 · see citing works

T cell immune memory after covid-19 and vaccination

Wang, L., Nicols, A. R., Turtle, L. C. W., Richter, A. G., Duncan, C. J. A., Dunachie, S. J., Klenerman, P., & Payne, R. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2022-000468 · Cited by 61 · see citing works

The 2022 Report on the Human Proteome from the HUPO Human Proteome Project

Omenn, G. S., Lane, L., Overall, C. M., Pineau, C., Packer, N. H., Cristea, I. M., Lindskog, C., Weintraub, S. T., Orchard, S. E., Roehrl, M. H. A., et al. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00498 · Cited by 60 · see citing works

High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform

Bruno, P. M., Timms, R. T., Abdelfattah, N. S., Leng, Y., Lelis, F., Wesemann, D. R., Yu, X. G., & Elledge, S. J. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01566-x · Cited by 48 · see citing works

T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations

Nersisyan, S. A., Zhiyanov, A., Shkurnikov, M. Y., & Tonevitsky, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab701 · Cited by 51 · see citing works

Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status

Yu, E. D., Wang, E. W., Garrigan, E., Goodwin, B., Sutherland, A., Tarke, A., Chang, J., Gálvez, R. I., Mateus, J., Ramirez, S. I., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.003 · Cited by 45 · see citing works

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets

Cheng, K., Martin‐Sancho, L., Pal, L. R., Pu, Y., Riva, L., Yin, X., Sinha, S., Nair, N. U., Chanda, S. K., & Ruppin, E. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110260 · Cited by 45 · see citing works

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants

Meyer, S., Blaas, I., Bollineni, R. C., Delić-Šarac, M., Tran, T. T., Knetter, C. F., Dai, K., Madssen, T. S., Vaage, J. T., Gustavsen, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.111995 · Cited by 40 · see citing works

Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model

Gomez‐Zepeda, D., Arnold-Schild, D., Beyrle, J., Declercq, A., Gabriels, R., Kumm, E. J., Preikschat, A., Łącki, M. K., Hirschler, A., Rijal, J. B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46380-y · Cited by 42 · see citing works

Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery

Zhang, B., & Bassani‐Sternberg, M. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007073 · Cited by 42 · see citing works

Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project

Omenn, G. S., Lane, L., Overall, C. M., Paik, Y., Cristea, I. M., Corrales, F. J., Lindskog, C., Weintraub, S. T., Roehrl, M. H. A., Liu, S., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00590 · Cited by 39 · see citing works

T-Cell Epitope-Based Vaccines: A Promising Strategy for Prevention of Infectious Diseases

Song, X., Li, Y., Wu, H., Qiu, H., & Sun, Y. (2024) · Vaccines · doi:10.3390/vaccines12101181 · Cited by 37 · see citing works

The biogenesis of the immunopeptidome

Admon, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101766 · Cited by 27 · see citing works

ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis

Xu, H., Hu, R., Dong, X., Kuang, L., Zhang, W., Tu, C., Li, Z., & Zhao, Z. (2024) · Nature Communications · doi:10.1038/s41467-024-53296-0 · Cited by 30 · see citing works

1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs

Stopfer, L. E., D’Souza, A. D., & White, F. M. (2021) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2021.100042 · Cited by 30 · see citing works

T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants

Nguyen, T. H. O., Cohen, C. A., Rowntree, L. C., Bull, M. B., Hachim, A., Kedzierska, K., & Valkenburg, S. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.793102 · Cited by 23 · see citing works

The 2023 Report on the Proteome from the HUPO Human Proteome Project

Omenn, G. S., Lane, L., Overall, C. M., Lindskog, C., Pineau, C., Packer, N. H., Cristea, I. M., Weintraub, S. T., Orchard, S. E., Roehrl, M. H. A., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00591 · Cited by 26 · see citing works

Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults

Samandari, T., Ongalo, J., McCarthy, K. D., Biegon, R., Madiega, P. A., Mithika, A., Orinda, J., Mboya, G., Mwaura, P., Anzala, O. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170011 · Cited by 24 · see citing works

IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma

Wahle, M., Thielert, M., Zwiebel, M., Skowronek, P., Zeng, W., & Mann, M. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100689 · Cited by 24 · see citing works

Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection

Khatamzas, E., Antwerpen, M. H., Rehn, A., Graf, A., Hellmuth, J. C., Hollaus, A., Mohr, A., Gaitzsch, E., Weiglein, T., Georgi, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32772-5 · Cited by 22 · see citing works

Viral T-cell epitopes – Identification, characterization and clinical application

Schroeder, S. M., Nelde, A., & Walz, J. S. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101725 · Cited by 24 · see citing works

Translational Control of COVID-19 and Its Therapeutic Implication

Zhang, D., Zhu, L., Wang, Y., Li, P., & Gao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857490 · Cited by 22 · see citing works

Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study

Hvidt, A. K., Guo, H., Andersen, R., Nielsen, S. S. F., Vibholm, L. K., Søgaard, O. S., Schleimann, M. H., Russell, V. R., Cheung, A. M., Paramithiotis, E., et al. (2023) · BMC Immunology · doi:10.1186/s12865-023-00583-y · Cited by 21 · see citing works

MhcVizPipe: A Quality Control Software for Rapid Assessment of Small- to Large-Scale Immunopeptidome Datasets

Kovalchik, K. A., Ma, Q., Wessling, L., Saab, F., Duquette, J. D., Kubiniok, P., Hamelin, D. J., Faridi, P., Li, C., Purcell, A. W., et al. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100178 · Cited by 22 · see citing works

SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity

Yang, G., Wang, J., Sun, P., Qin, J., Yang, X., Chen, D., Zhang, Y., Zhong, N. S., & Wang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146196 · Cited by 22 · see citing works

The cryptic immunopeptidome in health and disease

Kina, E., Larouche, J., Thibault, P., & Perreault, C. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.09.003 · Cited by 20 · see citing works

Leveraging Immunopeptidomics To Study and Combat Infectious Disease

Leddy, O. K., White, F. M., & Bryson, B. D. (2021) · mSystems · doi:10.1128/msystems.00310-21 · Cited by 20 · see citing works

Are There Hidden Genes in DNA/RNA Vaccines?

Beaudoin, C. A., Bartas, M., Volná, A., Pečínka, P., & Blundell, T. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801915 · Cited by 20 · see citing works

The HLA-II immunopeptidome of SARS-CoV-2

Weingarten-Gabbay, S., Chen, D. W., Sarkizova, S., Taylor, H. B., Gentili, M., Hernandez, G. M., Pearlman, L. R., Bauer, M. R., Rice, C. M., Clauser, K. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113596 · Cited by 20 · see citing works

Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity

Schetelig, J., Heidenreich, F., Baldauf, H., Trost, S., Falk, B., Hoßbach, C., Real, R. G. L., Roers, A., Lindemann, D., Dalpke, A. H., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.698193 · Cited by 18 · see citing works

T cells in SARS-CoV-2 infection and vaccination

Young, A. (2022) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355221115011 · Cited by 16 · see citing works

A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2

Jin, X., Liu, X. K., & Shen, C. (2022) · Virus Research · doi:10.1016/j.virusres.2022.199024 · Cited by 17 · see citing works

Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2

Becerra‐Artiles, A., Nanaware, P. P., Muneeruddin, K., Weaver, G. C., Shaffer, S. A., Calvo‐Calle, J. M., & Stern, L. J. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011032 · Cited by 16 · see citing works

HLA‐DPB1*13:01 associates with enhanced, and KIR2DS4*001 with diminished protection from developing severe COVID ‐19

Farias, T. D. J., Brugiapaglia, S., Croci, S., Magistroni, P., Curcio, C., Zguro, K., Fallerini, C., Fava, F., Pettini, F., Kichula, K. M., et al. (2023) · HLA · doi:10.1111/tan.15251 · Cited by 17 · see citing works

Immunopeptidomics in the Era of Single-Cell Proteomics

Mayer, R. L., & Mechtler, K. (2023) · Biology · doi:10.3390/biology12121514 · Cited by 17 · see citing works

Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

Delmonte, O. M., Oguz, C., Dobbs, K., Myint‐Hpu, K., Palterer, B., Abers, M. S., Draper, D., Truong, M., Kaplan, I. M., Gittelman, R., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.12.011 · Cited by 16 · see citing works

The HLA class-II immunopeptidomes of AAV capsids proteins

Brito-Sierra, C. A., Lannan, M. B., Siegel, R. W., & Malherbe, L. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1067399 · Cited by 15 · see citing works

Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population

Frasca, L., Ocone, G., & Palazzo, R. (2023) · Pathogens · doi:10.3390/pathogens12020233 · Cited by 15 · see citing works

Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines

Kovalchik, K. A., Hamelin, D. J., Kubiniok, P., Bourdin, B., Mostefai, F., Poujol, R., Paré, B., Simpson, S. M., Sidney, J., Bonneil, É., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54734-9 · Cited by 13 · see citing works

The Cold-Adapted, Temperature-Sensitive SARS-CoV-2 Strain TS11 Is Attenuated in Syrian Hamsters and a Candidate Attenuated Vaccine

Xu, J., Liu, M., Niu, X., Hanson, J., Jung, K., Ru, P., Tu, H., Jones, D. M., Vlasova, A. N., Saif, L. J., et al. (2022) · Viruses · doi:10.3390/v15010095 · Cited by 15 · see citing works

Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals

Natalini, A., Simonetti, S., Sher, C., D’Oro, U., Hayday, A., & Rosa, F. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214367 · Cited by 12 · see citing works

Endoplasmic Reticulum Stress in Elderly Patients with COVID-19: Potential of Melatonin Treatment

Yiang, G., Wu, C., Lu, C., Hu, W., Tsai, Y., Huang, Y., Su, W., & Lu, K. (2023) · Viruses · doi:10.3390/v15010156 · Cited by 12 · see citing works

Targeting infection-specific peptides in immunopeptidomics studies for vaccine target discovery

Leddy, O. K., Yuki, Y., Carrington, M. N., Bryson, B. D., & White, F. M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250444 · Cited by 11 · see citing works

Game of Omes: ribosome profiling expands the MHC-I immunopeptidome

Hollý, J., & Yewdell, J. W. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102342 · Cited by 12 · see citing works

Pan-viral ORFs discovery using Massively Parallel Ribosome Profiling

Weingarten-Gabbay, S., Bauer, M., Stanton, A. C., Yu, Y.-P., Freije, C., Welch, N., Boehm, C., Klaeger, S., Verzani, E. K., López, D., et al. (2025) · Science · doi:10.1126/science.ado6670 · Cited by 1 · see citing works

SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry

Lerner, A., Benzvi, C., & Vojdani, A. (2023) · Biomedicines · doi:10.3390/biomedicines11071937 · Cited by 11 · see citing works

Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology

Khanolkar, A. (2021) · Cells · doi:10.3390/cells11010067 · Cited by 12 · see citing works

MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissuesPreprint

Abelin, J. G., Bergstrom, E. J., Taylor, H. B., Rivera, K. D., Klaeger, S., Xu, C., White, C. J., Olive, M. E., Maynard, M., Kane, M. H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.22.449417 · Cited by 9 · see citing works

Nervous system‐related tropism of SARS‐CoV‐2 and autoimmunity in COVID‐19 infection

Weissert, R. (2023) · European Journal of Immunology · doi:10.1002/eji.202250230 · Cited by 10 · see citing works

Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile

Tang, X., Zhang, W., & Zhang, Z. (2025) · Vaccines · doi:10.3390/vaccines13020135 · Cited by 11 · see citing works

Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling

Bertrand, L., Nelde, A., Ramírez, B. C., Hatin, I., Arbès, H., François, P., Demais, S., Labaronne, E., Décimo, D., Guiguettaz, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56773-2 · Cited by 10 · see citing works

Molecular/antigenic mimicry and immunological cross-reactivity explains SARS-CoV-2-induced autoimmunity

Adıgüzel, Y., Bogdanos, D. P., & Shoenfeld, Y. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103811 · Cited by 10 · see citing works

Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity

Nelde, A., Rieth, J., Roerden, M., Dubbelaar, M. L., Gravel, N. H., Bauer, J., Klein, R., Hoheisel, T., Mahrhofer, H., Göpel, S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105643 · Cited by 10 · see citing works

Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development

Feng, L., Lin, X., Fu, B., Xiong, Y., Zaky, M. Y., & Wu, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121374 · Cited by 11 · see citing works

Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine

Patel, R. S., & Agrawal, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952229 · Cited by 10 · see citing works

Harnessing Noncanonical Proteins for Next‐Generation Drug Discovery and Diagnosis

Rajinikanth, N., Chauhan, R., & Prabakaran, S. (2025) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.70001 · Cited by 10 · see citing works

Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines

de Souza, W. M., Muraro, S. P., de Souza, G. F., Amorim, M. R., Sesti‐Costa, R., Mofatto, L. S., Forato, J., Barbosa, P. P., de Toledo-Teixeira, D. A., Bispo-dos-Santos, K., et al. (2021) · Viruses · doi:10.3390/v13112127 · Cited by 10 · see citing works

A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population

Kim, G., Elnaggar, J., Varnado, M., Feehan, A. K., Tauzier, D., Rose, R., Lamers, S. L., Sevalia, M., Nicholas, N., Gravois, E., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1357731 · Cited by 10 · see citing works

Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targetsPreprint

Cheng, K., Martin-Sancho, L., Pal, L. R., Pu, Y., Riva, L., Yin, X., Sinha, S., Nair, N. U., Chanda, S. K., & Ruppin, E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.27.428543 · Cited by 9 · see citing works

SARS-CoV-2: Immunopeptidomics and Other Immunological Studies

Chavda, V. P., & Redwan, E. M. M. M. (2022) · Vaccines · doi:10.3390/vaccines10111975 · Cited by 8 · see citing works

Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection

Chikata, T., Paes, W., Kuse, N., Partridge, T., Gatanaga, H., Zhang, Y., Kuroki, K., Maenaka, K., Ternette, N., Oka, S., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00432-22 · Cited by 8 · see citing works

Viral RNA blocks circularization to evade host codon usage control

Liu, H., Duan, J., Garg, R., Xie, P.-C., & Liu, Y. (2025) · Nature · doi:10.1038/s41586-025-09809-y · Cited by 8 · see citing works

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies

Yin, S., Klaeger, S., Chea, V. A., Carulli, I. P., Rachimi, S., Black, K. E., Filbin, M. R., Hariri, L. P., Knipe, R. S., Padera, R. F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269335 · Cited by 7 · see citing works

PEPSeek-Mediated Identification of Novel Epitopes From Viral and Bacterial Pathogens and the Impact on Host Cell Immunopeptidomes

Cormican, J. A., Medfai, L., Wawrzyniuk, M., Pašen, M., Afrache, H., Fourny, C., Khan, S. A., Gneiße, P., Soh, W. T., Timelli, A., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100937 · Cited by 7 · see citing works

Origins, Technological Advancement, and Applications of Peptidomics

Schrader, M. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3646-6_1 · Cited by 7 · see citing works

Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes

Braun, A., Rowntree, L. C., Huang, Z., Pandey, K., Thuesen, N. H., Li, C., Petersen, J., Littler, D. R., Raji, S., Nguyen, T. H. O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51959-6 · Cited by 7 · see citing works

Computational Structural and Functional Analyses of ORF10 in Novel Coronavirus SARS-CoV-2 Variants to Understand Evolutionary Dynamics

Mishra, S. (2022) · Evolutionary Bioinformatics · doi:10.1177/11769343221108218 · Cited by 7 · see citing works

Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection

Wagstaffe, H. R., Thwaites, R. S., Sidhu, J. K., Lindeboom, R. G. H., Kretschmer, L., Worlock, K. B., Dratva, L. M., Huang, A., Ascough, S., Papargyris, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67017-8 · Cited by 6 · see citing works

UreB immunodominant epitope‐specific CD8 +T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals

He, T., Zhang, F., Zhang, J., Wei, S., Ning, J., Yuan, H., & Li, B. (2023) · Helicobacter · doi:10.1111/hel.12959 · Cited by 6 · see citing works

A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides

Ratishvili, T., Quach, H. Q., Haralambieva, I. H., Suryawanshi, Y. R., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.024 · Cited by 6 · see citing works

Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs

Wu, K., Wang, D., Wang, J., & Zhou, Y. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.09.003 · Cited by 6 · see citing works

Identification of potential antigenic peptides of Brucella through proteome and peptidome

Pei, M., Dong, A., Ma, X., Li, S., Guo, Y., Li, M., Wang, Z., Wang, H., Li, Z., Pan, C., et al. (2022) · Veterinary Medicine and Science · doi:10.1002/vms3.1048 · Cited by 6 · see citing works

Predicting host-based, synthetic lethal antiviral targets from omics data

Staheli, J. P., Neal, M. L., Navare, A., Mast, F. D., & Aitchison, J. D. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugad001 · Cited by 6 · see citing works

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review

El‐Baky, N. A., Amara, A. A. A. F., & Redwan, E. M. M. M. (2023) · Vaccines · doi:10.3390/vaccines11030548 · Cited by 5 · see citing works

pXg: Comprehensive Identification of Noncanonical MHC-I–Associated Peptides From De Novo Peptide Sequencing Using RNA-Seq Reads

Choi, S., & Paek, E. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100743 · Cited by 5 · see citing works

Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire

Abt, E. R., Lam, A. K., Noguchi, M., Rashid, K., McLaughlin, J., Teng, P.-L., Tran, W., Cheng, D., Nesterenko, P. A., Mao, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406332121 · Cited by 5 · see citing works

PRR adjuvants restrain high stability peptides presentation on APCsPreprint

Li, B., Zhang, J., He, T., Yuan, H., Wu, H., Wang, P., & Wu, C. (2024) · eLife · doi:10.7554/elife.99173 · Cited by 5 · see citing works

A pan-cancer atlas of therapeutic T cell targetsPreprint

Li, G., Guzmán-Bringas, O. U., Sharma, A., Dellacherie, M. O., Sekhri, P., Yamin, R., Stepec, D., Burq, M., Clotea, I., Tardio, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.22.634237 · Cited by 5 · see citing works

Integrated Immunopeptidomics and Proteomics Study of SARS-CoV-2–Infected Calu-3 Cells Reveals Dynamic Changes in Allele-specific HLA Abundance and Antigen Presentation

Chen, R., Fulton, K. M., Tran, A., Duque, D., Kovalchik, K. A., Caron, É., Twine, S. M., & Li, J. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100645 · Cited by 4 · see citing works

Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8+ T Cell Responses Specific for Epitopes on Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein

Wang, Y., Yang, L., Tang, K., Zhang, Y., Zhang, C., Zhang, Y., Jin, B., Zhang, Y., Zhuang, R., & Ma, Y. (2023) · Viruses · doi:10.3390/v16010052 · Cited by 4 · see citing works

Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?

Chang, K. P., Reynolds, J. M., Liu, Y., & He, J. J. (2022) · Vaccines · doi:10.3390/vaccines10020248 · Cited by 4 · see citing works

Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?

Acharjee, A., Kingsly, J. S., Kamat, M., Kurlawala, V., Chakraborty, A., Vyas, P. A., Vaishnav, R. A., & Srivastava, S. (2022) · Espert Review of Proteomics · doi:10.1080/14789450.2022.2085564 · Cited by 3 · see citing works

Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implications

Sсherbak, S. G., Vologzhanin, D. A., Голота, А. С., Kamilova, Т. A., & Макаренко, С. В. (2022) · Journal of clinical practice · doi:10.17816/clinpract106239 · Cited by 5 · see citing works

HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses

Weingarten-Gabbay, S., Pearlman, L. R., Chen, D. W., Klaeger, S., Taylor, H. B., Welch, N. L., Keskin, D. B., Carr, S. A., Abelin, J. G., Saeed, M., et al. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101910 · Cited by 4 · see citing works

How mass spectrometric interrogation of MHC class I ligandomes has advanced our understanding of immune responses to viruses

Ternette, N., Adamopoulou, E., & Purcell, A. W. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101780 · Cited by 4 · see citing works

Uncommon P1 Anchor-featured Viral T Cell Epitope Preference within HLA-A*2601 and HLA-A*0101 Individuals

Zhang, J., Yue, C., Lin, Y., Tian, J., Guo, Y., Zhang, D., Guo, Y., Ye, B., Chai, Y., Qi, J., et al. (2024) · ImmunoHorizons · doi:10.4049/immunohorizons.2400026 · Cited by 4 · see citing works

SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFsPreprint

Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L., Chen, D.-Y., Bauer, M., Taylor, H. B., Conway, H. L., Tomkins-Tinch, C., Finkel, Y., et al. (2020) · bioRxiv · doi:10.1101/2020.10.02.324145 · Cited by 21 · see citing works

HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review

El‐Baky, N. A., Amara, A. A. A. F., & Redwan, E. M. M. M. (2023) · Vaccines · doi:10.3390/vaccines11030548 · Cited by 5 · see citing works

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Nagler, A., Kalaora, S., Barbolin, C., Gangaev, A., Ketelaars, S. L. C., Alon, M., Pai, J. A., Benedek, G., Yahalom-Ronen, Y., Noam Erez, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109305 · Cited by 46 · see citing works

Profiling MHC-I and MHC-II canonical and out-of-frame epitopes from SARS-CoV-2 and seasonal human coronavirus infected human cells

Nanaware, P. P., Becerra‐Artiles, A., Cruz, J., Calvo‐Calle, J. M., Khaja, M., Shaffer, S. A., & Stern, L. J. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.208.supp.102.14

The HLA-II immunopeptidome of SARS-CoV-2

Weingarten-Gabbay, S., Chen, D. W., Sarkizova, S., Taylor, H. B., Gentili, M., Hernandez, G. M., Pearlman, L. R., Bauer, M. R., Rice, C. M., Clauser, K. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113596 · Cited by 20 · see citing works